Critical Reviews in Oncology / Hematology
Volume 43, Issue 2 , Pages 159-165, August 2002

EORTC prostate cancer trials: what have we learnt?

  • Theo M. de Reijke

      Affiliations

    • Department of Urology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-20-5666004; fax: +31-20-6919647
    • ,
  • Laurence Collette

      Affiliations

    • EORTC Data Center, Statistician, Brussels, Belgium

Accepted 23 October 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(02)00028-8

Critical Reviews in Oncology / Hematology
Volume 43, Issue 2 , Pages 159-165, August 2002

Article Tools